Group One Trading
CGEM icon

Group One Trading’s Cullinan Oncology CGEM Stock Holding History

Group One Trading’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$126K Buy
+8,856
New +$114K ﹤0.01% 4518
2025
Q4 		– Hold
0
– – – 8417
2025
Q3 		– Hold
0
– – – 8686
2025
Q2 		– Sell
-389
Closed -$3.13K – 8239
2025
Q1 		$2.94K Buy
389
+373
+2,331% +$3.58K ﹤0.01% 6857
2024
Q4 		$195 Buy
+16
New +$230 ﹤0.01% 7067
2024
Q3 		– Sell
-14
Closed -$248 – 6906
2024
Q2 		$244 Hold
14
– – ﹤0.01% 6511
2024
Q1 		$239 Buy
+14
New +$216 ﹤0.01% 6796
2023
Q4 		– Sell
-43,182
Closed -$383K – 7666
2023
Q3 		$391K Buy
+43,182
New +$450K 0.02% 3163
2023
Q2 		– Hold
0
– – – 7907
2022
Q3 		– Hold
0
– – – 7778
2022
Q2 		– Sell
-100
Closed -$1.13K – 8062
2022
Q1 		$1K Buy
+100
New +$1.35K ﹤0.01% 7810

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return